Carmelo Rizzo

Grant enhances study of new chemotherapy targets

Vanderbilt chemists have been awarded $7.2 million over the next five years from the National Cancer Institute to lead an initiative to better understand how a combination chemotherapy for breast cancer targets DNA.

Carcinogenic chemicals cramp DNA

Researchers have determined how a DNA lesion caused by exposure to chemicals may spark cancer formation.

DNA: From modification to mutation

Understanding how an environmental hazard damages DNA may shed light on processes of tumor formation.